Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium-channel blocking agents and chest pain.

T S Gaginella1, D L Maxfield

  • 1Division of Gastroenterology, Ohio State University, Columbus.

Drug Intelligence & Clinical Pharmacy
|July 1, 1988
PubMed
Summary

Calcium-channel blockers may cause noncardiac chest pain by reducing esophageal sphincter pressure, mimicking cardiac pain. Clinicians should consider this potential side effect in patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide.

Trends in pharmacological sciences·1998
Same author

The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide.

Magnesium research·1996
Same author

Relationship between nitric oxide and platelet-activating factor in castor-oil induced mucosal injury in the rat duodenum.

Naunyn-Schmiedeberg's archives of pharmacology·1996
Same author

NG-nitro-L-arginine methyl ester reduces senna- and cascara-induced diarrhoea and fluid secretion in the rat.

European journal of pharmacology·1996
Same author

Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea.

Gastroenterology·1995
Same author

Eicosanoids and histamine mediate C5a-induced electrolyte secretion in guinea pig ileal mucosa.

Inflammation·1995

Area of Science:

  • Cardiology
  • Gastroenterology
  • Pharmacology

Background:

  • Calcium-channel blockers are used to treat anginal chest pain.
  • These agents can affect esophageal motility and pressure.
  • Lower esophageal sphincter pressure reduction may lead to gastroesophageal reflux.

Purpose of the Study:

  • To explore the potential link between calcium-channel blockers and noncardiac chest pain.
  • To differentiate drug-induced chest pain from cardiac pain.
  • To inform clinical management and future research.

Main Methods:

  • Review of existing literature on calcium-channel blockers and esophageal function.
  • Theoretical analysis of the pharmacological effects on the lower esophageal sphincter.
  • Clinical observation and case reporting (implied).

Main Results:

  • Calcium-channel blockers can reduce lower esophageal sphincter pressure.
  • This reduction may theoretically cause gastroesophageal reflux and chest pain.
  • The chest pain induced may be indistinguishable from cardiac pain.

Conclusions:

  • A potential association exists between calcium-channel blockers and noncardiac chest pain.
  • Clinicians must consider this possibility in patient assessment.
  • Further clinical studies are needed to confirm the incidence and mechanisms.

Related Experiment Videos